E
Neumora Therapeutics, Inc. NMRA
$1.28 -$0.12-8.57%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 62.54M 56.76M 56.01M 50.11M 45.48M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 263.46M 250.64M 230.86M 209.10M 188.19M
Operating Income -263.46M -250.64M -230.86M -209.10M -188.19M
Income Before Tax -243.61M -293.25M -273.79M -253.75M -235.66M
Income Tax Expenses 178.00K 446.00K 393.00K 268.00K 268.00K
Earnings from Continuing Operations -243.79 -293.70 -274.18 -254.02 -235.93
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -243.79M -293.70M -274.18M -254.02M -235.93M
EBIT -263.46M -250.64M -230.86M -209.10M -188.19M
EBITDA -262.83M -250.00M -230.20M -208.43M -187.53M
EPS Basic -1.53 -1.88 -2.56 -3.47 -4.34
Normalized Basic EPS -0.96 -0.91 -1.33 -1.90 -2.45
EPS Diluted -1.53 -1.88 -2.56 -3.47 -4.34
Normalized Diluted EPS -0.96 -0.91 -1.33 -1.90 -2.45
Average Basic Shares Outstanding 637.49M 629.34M 516.45M 387.59M 258.93M
Average Diluted Shares Outstanding 637.49M 629.34M 516.45M 387.59M 258.93M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings